Logo image of AMBA

AMBARELLA INC (AMBA) Stock Fundamental Analysis

NASDAQ:AMBA - Nasdaq - KYG037AX1015 - Common Stock - Currency: USD

78.2  -3.07 (-3.78%)

After market: 78.2 0 (0%)

Fundamental Rating

4

AMBA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for AMBA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, AMBA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AMBA has reported negative net income.
AMBA had a positive operating cash flow in the past year.
AMBA had negative earnings in each of the past 5 years.
In the past 5 years AMBA always reported a positive cash flow from operatings.
AMBA Yearly Net Income VS EBIT VS OCF VS FCFAMBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

AMBA has a Return On Assets of -23.48%. This is amonst the worse of the industry: AMBA underperforms 81.48% of its industry peers.
With a Return On Equity value of -28.41%, AMBA is not doing good in the industry: 78.70% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -23.48%
ROE -28.41%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A
AMBA Yearly ROA, ROE, ROICAMBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

The Gross Margin of AMBA (60.52%) is better than 85.19% of its industry peers.
In the last couple of years the Gross Margin of AMBA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%
AMBA Yearly Profit, Operating, Gross MarginsAMBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMBA has more shares outstanding
AMBA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMBA Yearly Shares OutstandingAMBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMBA Yearly Total Debt VS Total AssetsAMBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 17.02 indicates that AMBA is not in any danger for bankruptcy at the moment.
AMBA has a Altman-Z score of 17.02. This is amongst the best in the industry. AMBA outperforms 86.11% of its industry peers.
AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.02
ROIC/WACCN/A
WACC11.82%
AMBA Yearly LT Debt VS Equity VS FCFAMBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

AMBA has a Current Ratio of 2.84. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.84, AMBA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
AMBA has a Quick Ratio of 2.50. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
AMBA's Quick ratio of 2.50 is in line compared to the rest of the industry. AMBA outperforms 56.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.5
AMBA Yearly Current Assets VS Current LiabilitesAMBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

AMBA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.57%.
Looking at the last year, AMBA shows a decrease in Revenue. The Revenue has decreased by -2.18% in the last year.
Measured over the past years, AMBA shows a decrease in Revenue. The Revenue has been decreasing by -0.12% on average per year.
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%139.29%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%63.36%

3.2 Future

Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 28.42% on average per year.
Based on estimates for the next years, AMBA will show a very strong growth in Revenue. The Revenue will grow by 20.15% on average per year.
EPS Next Y62.94%
EPS Next 2Y33.89%
EPS Next 3Y32.31%
EPS Next 5Y28.42%
Revenue Next Year21.51%
Revenue Next 2Y18.54%
Revenue Next 3Y18.56%
Revenue Next 5Y20.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMBA Yearly Revenue VS EstimatesAMBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AMBA Yearly EPS VS EstimatesAMBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMBA. In the last year negative earnings were reported.
Also next year AMBA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMBA Price Earnings VS Forward Price EarningsAMBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMBA Per share dataAMBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

AMBA's earnings are expected to grow with 32.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.89%
EPS Next 3Y32.31%

More info and screens

0

5. Dividend

5.1 Amount

AMBA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBARELLA INC

NASDAQ:AMBA (2/21/2025, 8:01:00 PM)

After market: 78.2 0 (0%)

78.2

-3.07 (-3.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners85.09%
Inst Owner Change4.03%
Ins Owners2.81%
Ins Owner Change-2.79%
Market Cap3.26B
Analysts74
Price Target92.73 (18.58%)
Short Float %3.93%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)121.65%
Min EPS beat(2)33.67%
Max EPS beat(2)209.63%
EPS beat(4)4
Avg EPS beat(4)72.48%
Min EPS beat(4)18.46%
Max EPS beat(4)209.63%
EPS beat(8)8
Avg EPS beat(8)54.51%
EPS beat(12)12
Avg EPS beat(12)39.88%
EPS beat(16)16
Avg EPS beat(16)39.64%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)0.61%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)2.54%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)2
Avg Revenue beat(12)-1.02%
Revenue beat(16)6
Avg Revenue beat(16)-0.29%
PT rev (1m)1.52%
PT rev (3m)22.85%
EPS NQ rev (1m)87.38%
EPS NQ rev (3m)91.78%
EPS NY rev (1m)0%
EPS NY rev (3m)39.46%
Revenue NQ rev (1m)6.93%
Revenue NQ rev (3m)20.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.92
P/FCF N/A
P/OCF 745.53
P/B 5.88
P/tB 15.85
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.1
OCFY0.13%
SpS6.05
BVpS13.29
TBVpS4.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.48%
ROE -28.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.52%
FCFM N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.69%
Cap/Sales 3.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.5
Altman-Z 17.02
F-Score4
WACC11.82%
ROIC/WACCN/A
Cap/Depr(3y)64.48%
Cap/Depr(5y)49.96%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%139.29%
EPS Next Y62.94%
EPS Next 2Y33.89%
EPS Next 3Y32.31%
EPS Next 5Y28.42%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%63.36%
Revenue Next Year21.51%
Revenue Next 2Y18.54%
Revenue Next 3Y18.56%
Revenue Next 5Y20.15%
EBIT growth 1Y-1.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.38%
EBIT Next 3Y34.22%
EBIT Next 5Y32.4%
FCF growth 1Y-108.7%
FCF growth 3Y-35.2%
FCF growth 5Y-20.07%
OCF growth 1Y-92.66%
OCF growth 3Y-14.84%
OCF growth 5Y-4.93%